Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/dailymed/contraindication
| Subject | Object |
|---|---|
| dailymed-drugs:592 |
None.
|
| dailymed-drugs:1195 |
None.
|
| dailymed-drugs:1196 |
None.
|
| dailymed-drugs:1620 |
None.
|
| dailymed-drugs:1934 |
None.
|
| dailymed-drugs:1972 |
None.
|
| dailymed-drugs:2245 |
None.
|
| dailymed-drugs:2791 |
None.
|
| dailymed-drugs:2877 |
None.
|
| dailymed-drugs:2989 |
None.
|
| dailymed-drugs:3271 |
None.
|
| dailymed-drugs:3793 |
None.
|
| dailymed-drugs:4043 |
None.
|
| dailymed-drugs:1304 |
None.
|
| dailymed-drugs:3071 |
None.
|
| dailymed-drugs:3586 |
None.
|
| dailymed-drugs:65 |
None known.
|
| dailymed-drugs:123 |
None known.
|
| dailymed-drugs:145 |
None known.
|
| dailymed-drugs:321 |
None known.
|
| dailymed-drugs:470 |
None known.
|
| dailymed-drugs:477 |
None known.
|
| dailymed-drugs:578 |
None known.
|
| dailymed-drugs:579 |
None known.
|
| dailymed-drugs:825 |
None known.
|
| dailymed-drugs:853 |
None known.
|
| dailymed-drugs:861 |
None known.
|
| dailymed-drugs:906 |
None known.
|
| dailymed-drugs:1036 |
None known.
|
| dailymed-drugs:1099 |
None known.
|
| dailymed-drugs:1136 |
None known.
|
| dailymed-drugs:1168 |
None known.
|
| dailymed-drugs:1174 |
None known.
|
| dailymed-drugs:1232 |
None known.
|
| dailymed-drugs:1238 |
None known.
|
| dailymed-drugs:1295 |
None known.
|
| dailymed-drugs:1703 |
None known.
|
| dailymed-drugs:1734 |
None known.
|
| dailymed-drugs:1742 |
None known.
|
| dailymed-drugs:1765 |
None known.
|
| dailymed-drugs:1829 |
None known.
|
| dailymed-drugs:1853 |
None known.
|
| dailymed-drugs:1904 |
None known.
|
| dailymed-drugs:1938 |
None known.
|
| dailymed-drugs:1965 |
None known.
|
| dailymed-drugs:2116 |
None known.
|
| dailymed-drugs:2189 |
None known.
|
| dailymed-drugs:2351 |
None known.
|
| dailymed-drugs:2425 |
None known.
|
| dailymed-drugs:2527 |
None known.
|
| dailymed-drugs:2746 |
None known.
|
| dailymed-drugs:2946 |
None known.
|
| dailymed-drugs:2957 |
None known.
|
| dailymed-drugs:3122 |
None known.
|
| dailymed-drugs:3238 |
None known.
|
| dailymed-drugs:3345 |
None known.
|
| dailymed-drugs:3436 |
None known.
|
| dailymed-drugs:3491 |
None known.
|
| dailymed-drugs:3662 |
None known.
|
| dailymed-drugs:3755 |
None known.
|
| dailymed-drugs:3800 |
None known.
|
| dailymed-drugs:3839 |
None known.
|
| dailymed-drugs:3886 |
None known.
|
| dailymed-drugs:3924 |
None known.
|
| dailymed-drugs:3950 |
None known.
|
| dailymed-drugs:4016 |
None known.
|
| dailymed-drugs:4031 |
None known.
|
| dailymed-drugs:4200 |
None known.
|
| dailymed-drugs:4267 |
None known.
|
| dailymed-drugs:926 |
Please refer to the package insert for ProstaScint or Zevalin for
this information on the final drug product.
|
| dailymed-drugs:1 |
Cefizox (ceftizoxime for injection, USP) is contraindicated in patients who have known allergy to the drug.
|
| dailymed-drugs:808 |
Cefizox (ceftizoxime for injection, USP) is contraindicated in patients who have known allergy to the drug.
|
| dailymed-drugs:2 |
FLOVENT DISKUS is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. Hypersensitivity to any of the ingredients of these preparations contraindicates their use (see DESCRIPTION and ADVERSE REACTIONS: Observed During Clinical Practice: Non-Site Specific).
|
| dailymed-drugs:3 |
Nadolol is contraindicated in bronchial asthma, sinus bradycardia and greater than first degree conduction block, cardiogenic shock, and overt cardiac failure (see WARNINGS).
|
| dailymed-drugs:4 |
Kepivance is contraindicated in patients with known hypersensitivity to E coli-derived proteins, palifermin, or any other component of the product.
|
| dailymed-drugs:5 |
Mepivacaine is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type or to other components of mepivacaine solutions.
|
| dailymed-drugs:6 |
The use of MUSTARGEN is contraindicated in the presence of known infectious diseases and in patients who have had previous anaphylactic reactions to MUSTARGEN.
|
| dailymed-drugs:7 |
Fluconazole is contraindicated in patients who have shown hypersensitivity to fluconazole or to any of its excipients. There is no information regarding cross-hypersensitivity between fluconazole and other azole antifungal agents. Caution should be used in prescribing fluconazole to patients with hypersensitivity to other azoles. Coadministration of terfenadine is contraindicated in patients receiving fluconazole at multiple doses of 400 mg or higher based upon results of a multiple dose interaction study. Coadministration of cisapride is contraindicated in patients receiving fluconazole.
|
| dailymed-drugs:1786 |
Fluconazole is contraindicated in patients who have shown hypersensitivity to fluconazole or to any of its excipients. There is no information regarding cross-hypersensitivity between fluconazole and other azole antifungal agents. Caution should be used in prescribing fluconazole to patients with hypersensitivity to other azoles. Coadministration of terfenadine is contraindicated in patients receiving fluconazole at multiple doses of 400 mg or higher based upon results of a multiple dose interaction study. Coadministration of cisapride is contraindicated in patients receiving fluconazole.
|
| dailymed-drugs:3295 |
Fluconazole is contraindicated in patients who have shown hypersensitivity to fluconazole or to any of its excipients. There is no information regarding cross-hypersensitivity between fluconazole and other azole antifungal agents. Caution should be used in prescribing fluconazole to patients with hypersensitivity to other azoles. Coadministration of terfenadine is contraindicated in patients receiving fluconazole at multiple doses of 400 mg or higher based upon results of a multiple dose interaction study. Coadministration of cisapride is contraindicated in patients receiving fluconazole.
|
| dailymed-drugs:8 |
PRED FORTE suspension is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. PRED FORTE suspension is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.
|
| dailymed-drugs:10 |
Betimol is contraindicated in patients with overt heart failure, cardiogenic shock, sinus bradycardia, second- or third-degree atrioventricular block, bronchial asthma or history of bronchial asthma, or severe chronic obstructive pulmonary disease, or hypersensitivity to any component of this product.
|
| dailymed-drugs:11 |
CHEMET should not be administered to patients with a history of allergy to the drug.
|
| dailymed-drugs:12 |
REMERON' (mirtazapine) Tablets
are contraindicated in patients with a known hypersensitivity to
mirtazapine.
|
| dailymed-drugs:14 |
BenzaClin Topical Gel is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. It is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.
|
| dailymed-drugs:2267 |
BenzaClin Topical Gel is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. It is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.
|
| dailymed-drugs:15 |
A history of a previous hypersensitivity reaction
to any of the penicillins is a contraindication.
|
| dailymed-drugs:16 |
Solutions
containing dextrose may be contraindicated in patients with known
allergy to corn or corn products.
|
| dailymed-drugs:102 |
Solutions
containing dextrose may be contraindicated in patients with known
allergy to corn or corn products.
|
| dailymed-drugs:1641 |
Solutions
containing dextrose may be contraindicated in patients with known
allergy to corn or corn products.
|
| dailymed-drugs:1942 |
Solutions
containing dextrose may be contraindicated in patients with known
allergy to corn or corn products.
|
| dailymed-drugs:1948 |
Solutions
containing dextrose may be contraindicated in patients with known
allergy to corn or corn products.
|
| dailymed-drugs:2056 |
Solutions
containing dextrose may be contraindicated in patients with known
allergy to corn or corn products.
|
| dailymed-drugs:3091 |
Solutions
containing dextrose may be contraindicated in patients with known
allergy to corn or corn products.
|
| dailymed-drugs:3389 |
Solutions
containing dextrose may be contraindicated in patients with known
allergy to corn or corn products.
|
| dailymed-drugs:17 |
Amantadine Hydrochloride is contraindicated in patients with known hypersensitivity to amantadine hydrochloride or to any of the other ingredients in Amantadine Hydrochloride Oral Solution.
|
| dailymed-drugs:18 |
Hypersensitivity to dipyridamole and any of the other components.
|
| dailymed-drugs:426 |
Hypersensitivity to dipyridamole and any of the other components.
|
| dailymed-drugs:3454 |
Hypersensitivity to dipyridamole and any of the other components.
|
| dailymed-drugs:19 |
A previous hypersensitivity reaction to any penicillin is
a contraindication.
|
| dailymed-drugs:20 |
Quinapril tablets are contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an ACE inhibitor.
|
| dailymed-drugs:2818 |
Quinapril tablets are contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an ACE inhibitor.
|
| dailymed-drugs:21 |
Dipivefrin hydrochloride should not be used in patients with narrow angles since any dilation of the pupil may predispose the patient to an attack of angle-closure glaucoma. This product is contraindicated in patients who are hypersensitive to any of its components.
|
| dailymed-drugs:1158 |
Dipivefrin hydrochloride should not be used in patients with narrow angles since any dilation of the pupil may predispose the patient to an attack of angle-closure glaucoma. This product is contraindicated in patients who are hypersensitive to any of its components.
|
| dailymed-drugs:22 |
This solution is contraindicated where the administration of sodium, potassium, calcium, or chloride could be clinically detrimental.
|
| dailymed-drugs:23 |
NuvaRing' should
not be used in women who currently have the following conditions:
|
| dailymed-drugs:24 |
Nystatin Ointment is contraindicated in patients with a history of hypersensitivity to any of its components.
|
| dailymed-drugs:25 |
Surmontil is contraindicated in cases of known hypersensitivity to the drug. The possibility of cross-sensitivity to other dibenzazepine compounds should be kept in mind. Surmontil should not be given in conjunction with drugs of the monoamine oxidase inhibitor class (e.g., tranylcypromine, isocarboxazid or phenelzine sulfate). The concomitant use of monoamine oxidase inhibitors (MAOI) and tricyclic compounds similar to Surmontil has caused severe hyperpyretic reactions, convulsive crises, and death in some patients. At least two weeks should elapse after cessation of therapy with MAOI before instituting therapy with Surmontil. Initial dosage should be low and increased gradually with caution and careful observation of the patient. The drug is contraindicated during the acute recovery period after a myocardial infarction.
|
| dailymed-drugs:26 |
LACRISERT is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.
|
| dailymed-drugs:28 |
14.6% Sodium Chloride Injection, USP Additive Solution is
contraindicated in patients with hypernatremia or fluid retention.
|
| dailymed-drugs:30 |
The use of PLAVIX is contraindicated
in the following conditions:
|
| dailymed-drugs:31 |
Nyamyc���(Nystatin Topical Powder, USP) is contraindicated in patients with a history of hypersensitivity to any of its components.
|
| dailymed-drugs:32 |
Amiodarone Hydrochloride Injection is contraindicated in patients with known hypersensitivity to any of the components of amiodarone including iodine, or in patients with cardiogenic shock, marked sinus bradycardia, and second- or third-degree AV block unless a functioning pacemaker is available.
|
| dailymed-drugs:33 |
The preparation is contraindicated in patients with a history of hypersensitivity to any of its components.
|
| dailymed-drugs:2049 |
The preparation is contraindicated in patients with a history of hypersensitivity to any of its components.
|
| dailymed-drugs:2889 |
The preparation is contraindicated in patients with a history of hypersensitivity to any of its components.
|
| dailymed-drugs:3033 |
The preparation is contraindicated in patients with a history of hypersensitivity to any of its components.
|
| dailymed-drugs:3629 |
The preparation is contraindicated in patients with a history of hypersensitivity to any of its components.
|
| dailymed-drugs:3690 |
The preparation is contraindicated in patients with a history of hypersensitivity to any of its components.
|
| dailymed-drugs:35 |
Etodolac is contraindicated in patients with known hypersensitivity to etodolac. Etodolac should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients (see WARNINGS, Anaphylactoid Reactions and PRECAUTIONS, Pre-existing Asthma). Etodolac is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery (see WARNINGS).
|
| dailymed-drugs:36 |
Geocillin is ordinarily contraindicated in patients who have a known penicillin allergy.
|
| dailymed-drugs:37 |
Mirtazapine tablets are contraindicated in patients with a known hypersensitivity to mirtazapine.
|
| dailymed-drugs:1819 |
Mirtazapine tablets are contraindicated in patients with a known hypersensitivity to mirtazapine.
|
| dailymed-drugs:3626 |
Mirtazapine tablets are contraindicated in patients with a known hypersensitivity to mirtazapine.
|
| dailymed-drugs:38 |
Irinotecan Hydrochloride Injection is contraindicated in patients with a known hypersensitivity to the drug or its excipients.
|
| dailymed-drugs:39 |
PROMETRIUM Capsules should not be used in women with any of the following conditions:
|
| dailymed-drugs:41 |
This preparation should not be used in patients with
hepatic coma or metabolic disorders involving impaired nitrogen utilization.
|
| dailymed-drugs:154 |
This preparation should not be used in patients with
hepatic coma or metabolic disorders involving impaired nitrogen utilization.
|
| dailymed-drugs:3032 |
This preparation should not be used in patients with
hepatic coma or metabolic disorders involving impaired nitrogen utilization.
|
| dailymed-drugs:42 |
Systemic fungal
infections (see WARNINGS
regarding amphotericin B). Hypersensitivity to
any component of this product, including sulfites .
|
| dailymed-drugs:43 |
Bupivacaine Hydrochloride is contraindicated in obstetrical
paracervical block anesthesia. Its use in this technique has resulted
in fetal bradycardia and death. Bupivacaine
Hydrochloride is contraindicated in patients with a known hypersensitivityto it or to any local anesthetic agent of the amide-type or to other
components of Bupivacaine Hydrochloride solutions.
|
| dailymed-drugs:46 |
Granisetron hydrochloride tablets are contraindicated in patients with known hypersensitivity to the drug or any of its components.
|
| dailymed-drugs:47 |
Percutaneous transhepatic cholangiography is contraindicated in patients with coagulation defects and prolonged prothrombin times until normal, or near normal, coagulation is achieved, eg, with vitamin K.
|
| dailymed-drugs:48 |
Axid is contraindicated in patients with known hypersensitivity to the drug. Because cross-sensitivity in this class of compounds has been observed, H- receptor antagonists, including Axid, should not be administered to patients with a history of hypersensitivity to other H-receptor antagonists.
|
| dailymed-drugs:49 |
The infusion of
hypertonic dextrose injections is contraindicated in patients having
intracranial or intraspinal hemorrhage, in patients who are severely
dehydrated, in patients who are anuric, and in patients in hepatic coma. Solutions
containing dextrose may be contraindicated in patients with known
allergy to corn or corn products.
|
| dailymed-drugs:1791 |
The infusion of
hypertonic dextrose injections is contraindicated in patients having
intracranial or intraspinal hemorrhage, in patients who are severely
dehydrated, in patients who are anuric, and in patients in hepatic coma. Solutions
containing dextrose may be contraindicated in patients with known
allergy to corn or corn products.
|
| dailymed-drugs:52 |
Phenytoin is contraindicated in patients with a history of hypersensitivity to hydantoin products. Because of its effect on ventricular automaticity, phenytoin is contraindicated in sinus bradycardia, sino-atrial block, second-
and third-degree A-V block, and patients with Adams-Stokes syndrome.
|
| dailymed-drugs:53 |
CASODEX is contraindicated in any patient who has shown a hypersensitivity reaction to the drug or any of the tablet's components. CASODEX has no indication for women, and should not be used in this population, particularly for non-serious or non-life threatening conditions. Further, CASODEX should not be used by women who are or may become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. CASODEX may cause fetal harm when administered to pregnant women. The male offspring of rats receiving doses of 10 mg/kg/day (plasma drug concentrations in rats equal to approximately 2/3 human therapeutic concentrations*) and above were observed to have reduced anogenital distance and hypospadias in reproductive toxicology studies. These pharmacological effects have been observed with other antiandrogens. No other teratogenic effects were observed in rabbits receiving doses up to 200 mg/kg/day (approximately 1/3 human therapeutic concentrations*) or rats receiving doses up to 250 mg/kg/day (approximately 2 times human therapeutic concentrations*). *Based on a maximum dose of 50 mg/day of bicalutamide for an average 70 kg patient.
|
| dailymed-drugs:54 |
Rifampin is contraindicated in patients with a history of hypersensitivity to any of the rifamycins.
|
| dailymed-drugs:587 |
Rifampin is contraindicated in patients with a history of hypersensitivity to any of the rifamycins.
|
| dailymed-drugs:2050 |
Rifampin is contraindicated in patients with a history of hypersensitivity to any of the rifamycins.
|
| dailymed-drugs:55 |
Cephalexin Capsules, USP is contraindicated in patients with known allergy to the cephalosporin group of antibiotics.
|
| dailymed-drugs:56 |
Known hypersensitivity reaction to nifedipine.
|
| dailymed-drugs:1497 |
Known hypersensitivity reaction to nifedipine.
|
| dailymed-drugs:2883 |
Known hypersensitivity reaction to nifedipine.
|
| dailymed-drugs:2884 |
Known hypersensitivity reaction to nifedipine.
|
| dailymed-drugs:58 |
Glipizide and metformin hydrochloride tablets are contraindicated in patients with: Glipizide and metformin hydrochloride tablets should be temporarily discontinued in patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials, because use of such products may result in acute alteration of renal function. (See also PRECAUTIONS.)
|
| dailymed-drugs:59 |
BUSULFEX is contraindicated in patients with a history of hypersensitivity to any of its components.
|
| dailymed-drugs:60 |
Intravenous magnesium should not be given to mothers with
toxemia of pregnancy during the two hours preceding delivery.
|
| dailymed-drugs:61 |
Concomitant use in patients taking either monoamine oxidase inhibitors (MAOIs) or thioridazine is contraindicated (see WARNINGS and PRECAUTIONS). Concomitant use in patients taking pimozide is contraindicated (see PRECAUTIONS). Paroxetine tablets are contraindicated in patients with a hypersensitivity to paroxetine or any of the inactive ingredients in paroxetine tablets.
|
| dailymed-drugs:62 |
Diphenoxylate HCl and Atropine Sulfate tablets are contraindicated in patients with:
|
| dailymed-drugs:63 |
Concomitant use in patients taking either monoamine oxidase inhibitors (MAOIs) or thioridazine is contraindicated (see
WARNINGS and PRECAUTIONS). Concomitant use in patients taking pimozide is contraindicated (see PRECAUTIONS). Paroxetine is contraindicated in patients with a hypersensitivity to paroxetine or any of the inactive ingredients in paroxetine.
|
| dailymed-drugs:64 |
Heparin sodium should not be used in patients: With
severe thrombocytopenia; In whom suitable blood coagulation
tests���e.g., the whole blood clotting time, partial thromboplastin
time, etc.���cannot be performed at appropriate intervals (this contraindication
refers to full-dose heparin; there is usually no need to monitor coagulation
parameters in patients receiving low-dose heparin); With
an uncontrollable active bleeding state (see WARNINGS), except when this is
due to disseminated intravascular coagulation.
|
| dailymed-drugs:66 |
Aminosyn-HF 8% (amino acid injection 8%) is contraindicated
in patients with anuria, inborn errors of amino acid metabolism, especially
those involving branched chain amino acid metabolism such as Maple Syrup Urine
Disease and Isovaleric Acidemia, or hypersensitivity to one or more amino
acids present in the solution.
|
| dailymed-drugs:68 |
TEMODAR (temozolomide) Capsules are contraindicated in patients who have a history of hypersensitivity reaction to any of its components. TEMODAR is also contraindicated in patients who have a history of hypersensitivity to DTIC, since both drugs are metabolized to MTIC.
|
| dailymed-drugs:70 |
The use of Coly-Mycin M Parenteral is contraindicated for
patients with a history of sensitivity to the drug or any of its components.
|
| dailymed-drugs:71 |
Concomitant use in patients taking monoamine oxidase inhibitors (MAOIs) is contraindicated . Concomitant use in patients taking pimozide is contraindicated . Citalopram HBr is contraindicated in patients with a hypersensitivity to citalopram or any of the inactive ingredients in citalopram HBr tablets.
|
| dailymed-drugs:72 |
Promethazine HCl suppositories are contraindicated for use in pediatric patients less than two years of age. Promethazine HCl suppositories are contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenolhiazines. Antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms including asthma.
|
| dailymed-drugs:73 |
Should not be used in those persons showing hypersensitivity to any of the components of this preparation.
|
| dailymed-drugs:4107 |
Should not be used in those persons showing hypersensitivity to any of the components of this preparation.
|
| dailymed-drugs:74 |
Verapamil hydrochloride is contraindicated in:
|
| dailymed-drugs:842 |
Verapamil hydrochloride is contraindicated in:
|
| dailymed-drugs:75 |
Ethionamide is contraindicated in patients with severe
hepatic impairment and in patients who are hypersensitive to the drug.
|
| dailymed-drugs:76 |
ZOVIRAX Cream is
contraindicated in patients with known hypersensitivity to acyclovir, valacyclovir,
or any component of the formulation.
|
| dailymed-drugs:77 |
Topical corticosteroids are contraindicated in those patients with a history of hypersensivity to any of the components of the preparation.
|
| dailymed-drugs:78 |
Fluticasone propionate ointment is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
|
| dailymed-drugs:80 |
Oxcarbazepine tablets should not be used in patients with a known hypersensitivity to oxcarbazepine or to any of its components.
|
| dailymed-drugs:81 |
Hydroxyurea is contraindicated in patients with marked bone marrow
depression, i.e., leukopenia (<2500 WBC) or thrombocytopenia (<100,000),
or severe anemia. HYDREA is contraindicated in patients who have demonstrated a previous
hypersensitivity to hydroxyurea or any other component of its formulation.
|
| dailymed-drugs:83 |
Cromolyn sodium ophthalmic solution, USP 4% is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium or to any of the other ingredients.
|
| dailymed-drugs:85 |
A history of a previous hypersensitivity reaction to any penicillin is a contraindication.
|
| dailymed-drugs:3700 |
A history of a previous hypersensitivity reaction to any penicillin is a contraindication.
|
| dailymed-drugs:87 |
ClomiPRAMINE hydrochloride capsules are contraindicated in patients with a history of hypersensitivity to ClomiPRAMINE or other tricyclic antidepressants. ClomiPRAMINE should not be given in combination, or within 14 days before or after treatment, with a monoamine oxidase (MAO) inhibitor. Hyperpyretic crisis, seizures, coma, and death have been reported in patients receiving such combinations. ClomiPRAMINE is contraindicated during the acute recovery period after a myocardial infarction.
|
| dailymed-drugs:88 |
INDOCIN I.V. is contraindicated in: neonates with proven or suspected infection that is untreated; neonates who are bleeding, especially those with active intracranial hemorrhage or gastrointestinal bleeding; neonates with thrombocytopenia; neonates with coagulation defects; neonates with or who are suspected of having necrotizing enterocolitis; neonates with significant impairment of renal function; neonates with congenital heart disease in whom patency of the ductus arteriosus is necessary for satisfactory pulmonary or systemic blood flow (e.g., pulmonary atresia, severe tetralogy of Fallot, severe coarctation of the aorta).
|
| dailymed-drugs:89 |
Use of the injectable form of Tigan in children and
use of any dosage form in patients with known hypersensitivity to
trimethobenzamide are contraindicated.
|
| dailymed-drugs:90 |
SEROQUEL is contraindicated in individuals with a known hypersensitivity to this medication or any of its ingredients.
|
| dailymed-drugs:92 |
This drug is contraindicated in individuals with a history of hypersensitivity
to preparations containing clindamycin or lincomycin.
|
| dailymed-drugs:93 |
Use of mefloquine hydrochloride tablets are contraindicated in patients with a known hypersensitivity to mefloquine or related compounds (eg, quinine and quinidine) or to any of the excipients contained in the formulation. Mefloquine hydrochloride tablets should not be prescribed for prophylaxis in patients with active depression, a recent history of depression, generalized anxiety disorder, psychosis, or schizophrenia or other major psychiatric disorders, or with a history of convulsions.
|
| dailymed-drugs:94 |
ARIXTRA Injection is contraindicated in patients
with severe renal impairment (creatinine clearance<30 mL/min).
ARIXTRA is eliminated primarily by the kidneys, and such patients
are at increased risk for major bleeding episodes (see WARNINGS: Renal
Impairment). ARIXTRA prophylactic therapy
is contraindicated in patients with body weight<50 kg undergoing
hip fracture, hip replacement or knee replacement surgery, and abdominal
surgery. During the randomized clinical trials of prophylaxis in the
peri-operative period following hip fracture, hip replacement, or
knee replacement surgery, occurrence of major bleeding was doubled
in patients with a body weight<50 kg compared with those
with a body weight���50 kg (5.4% versus 2.1%). In the clinical
trial in patients undergoing abdominal surgery, the major bleeding
rate was also higher in patients with a body weight<50 kg
as compared to those with a body weight���50 kg (5.3% versus
3.3%), respectively. The use of ARIXTRA
is contraindicated in patients with active major bleeding, bacterial
endocarditis, in patients with thrombocytopenia associated with a
positive in vitro test for anti-platelet antibody in the presence
of fondaparinux sodium, or in patients with known hypersensitivity
to fondaparinux sodium.
|
| dailymed-drugs:95 |
Ridaura (auranofin) is contraindicated in patients with a history of any of the following gold-induced disorders: anaphylactic reactions, necrotizing enterocolitis, pulmonary fibrosis, exfoliative dermatitis, bone marrow aplasia or other severe hematologic disorders.
|
| dailymed-drugs:96 |
Ipratropium Bromide Nasal Spray 0.03% is contraindicated in patients with a history of hypersensitivity to atropine or its derivatives, or to any of the other ingredients.
|
| dailymed-drugs:97 |
Bumetanide is contraindicated in anuria. Although bumetanide can be used to induce diuresis in renal insufficiency, any marked increase in blood urea nitrogen or creatinine, or the development of oliguria during therapy of patients with progressive renal disease, is an indication for discontinuation of treatment with bumetanide. Bumetanide is also contraindicated in patients in hepatic coma or in states of severe electrolyte depletion until the condition is improved or corrected. Bumetanide is contraindicated in patients hypersensitive to this drug.
|
| dailymed-drugs:98 |
Hypersensitivity to hydralazine; coronary artery disease; mitral valvular rheumatic heart disease.
|
| dailymed-drugs:343 |
Hypersensitivity to hydralazine; coronary artery disease; mitral valvular rheumatic heart disease.
|
| dailymed-drugs:1383 |
Hypersensitivity to hydralazine; coronary artery disease; mitral valvular rheumatic heart disease.
|
| dailymed-drugs:99 |
Prednisolone Acetate Ophthalmic Suspension USP, 1% is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. Prednisolone Acetate Ophthalmic Suspension USP, 1% is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.
|
| dailymed-drugs:100 |
RIOMET is contraindicated in patients with: 1. Renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels���1.5 mg/dL [males],���1.4 mg/dL [females] or abnormal creatinine clearance) which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and septicemia (see WARNINGS and PRECAUTIONS). 2. Known hypersensitivity to metformin hydrochloride. 3. Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. Diabetic ketoacidosis should be treated with insulin. RIOMET should be temporarily discontinued in patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials, because use of such products may result in acute alteration of renal function. (See also PRECAUTIONS.)
|
| dailymed-drugs:104 |
CEFAZOLIN FOR INJECTION, USP IS CONTRAINDICATED IN PATIENTS WITH KNOWN ALLERGY TO THE CEPHALOSPORIN GROUP OF ANTIBIOTICS.
|
| dailymed-drugs:461 |
CEFAZOLIN FOR INJECTION, USP IS CONTRAINDICATED IN PATIENTS WITH KNOWN ALLERGY TO THE CEPHALOSPORIN GROUP OF ANTIBIOTICS.
|
| dailymed-drugs:105 |
Diclofenac sodium ophthalmic solution is contraindicated in patients who are hypersensitive to any component of the medication.
|
| dailymed-drugs:106 |
This drug is contraindicated in patients with a history of hypersensitivity to erythromycin.
|
| dailymed-drugs:107 |
NOLVADEX is contraindicated in patients with known hypersensitivity to the drug or any of its ingredients.<br/>Reduction in Breast Cancer Incidence in High Risk Women and Women with DCIS:: NOLVADEX is contraindicated in women who require concomitant coumarin-type anticoagulant therapy or in women with a history of deep vein thrombosis or pulmonary embolus.
|
| dailymed-drugs:108 |
COREG CR is contraindicated in patients with
bronchial asthma (2 cases of death from status asthmaticus have been
reported in patients receiving single doses of immediate-release carvedilol)
or related bronchospastic conditions, second- or third-degree AV block,
sick sinus syndrome or severe bradycardia (unless a permanent pacemaker
is in place), or in patients with cardiogenic shock or who have decompensated
heart failure requiring the use of intravenous inotropic therapy.
Such patients should first be weaned from intravenous therapy before
initiating COREG CR. Use of COREG CR
in patients with clinically manifest hepatic impairment is not recommended. COREG CR is contraindicated in patients with a history
of a serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome,
anaphylactic reaction, angioedema) to carvedilol or any of the components
of COREG CR.
|
| dailymed-drugs:109 |
YAZ should not be used in women who have the following:
|
| dailymed-drugs:110 |
Telbivudine tablets are contraindicated in patients with previously demonstrated hypersensitivity to any component of the product.
|
| dailymed-drugs:111 |
Cevimeline is contraindicated in patients with uncontrolled asthma, known hypersensitivity to cevimeline, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle-closure) glaucoma.
|
| dailymed-drugs:112 |
IQUIX solution is contraindicated in patients with a history of hypersensitivity to levofloxacin, to other quinolones, or to any of the components in this medication.
|
| dailymed-drugs:113 |
Meloxicam is contraindicated in patients with known hypersensitivity to meloxicam. Meloxicam should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients . Meloxicam is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery .
|
| dailymed-drugs:2475 |
Meloxicam is contraindicated in patients with known hypersensitivity to meloxicam. Meloxicam should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients . Meloxicam is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery .
|
| dailymed-drugs:2661 |
Meloxicam is contraindicated in patients with known hypersensitivity to meloxicam. Meloxicam should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients . Meloxicam is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery .
|
| dailymed-drugs:114 |
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
|